Management of Pyogenic Liver Abscesses

Pyogenic liver abscesses represent a serious intrahepatic infection requiring prompt diagnosis and a coordinated therapeutic strategy. Clinical suspicion arises in patients presenting with fever, right upper quadrant pain and elevated inflammatory markers. Imaging techniques, notably ultrasound and contrast-enhanced computed tomography, are essential for confirming abscess size, number and loculation. Empirical broad-spectrum antibiotic therapy is initiated early, with adjustment guided by culture or molecular identification of pathogens. Percutaneous drainage under radiological guidance has become the cornerstone of intervention for most abscesses larger than 5 cm or those that fail to respond to medical therapy. Surgical drainage remains reserved for complex, multiloculated or giant abscesses, or where percutaneous techniques prove unsuccessful. Attention to underlying comorbidities, such as diabetes and obesity, is crucial since poor glycaemic control and elevated body mass index both increase incidence and worsen outcomes. Emerging molecular diagnostics, including 16S rRNA sequencing, have enhanced detection of unusual or culture-negative pathogens, informing targeted antimicrobial regimens. A multidisciplinary approach encompassing hepatology, microbiology, interventional radiology and surgery ensures optimisation of patient care and minimises morbidity.

Research from Nature Portfolio

Recent cohort analysis has demonstrated that poorly controlled diabetes markedly elevates the risk of pyogenic liver abscess, with those exhibiting fasting plasma glucose above 130 mg/dl experiencing more than threefold higher incidence compared to non-diabetic individuals. Overweight and obese participants also showed significantly increased hazard ratios for abscess development, emphasising the importance of metabolic optimisation in prevention strategies. A foundational retrospective review categorised abscesses by size and revealed that small lesions (<5 cm) often respond to antibiotics alone, whereas large (5–10 cm) and giant (>10 cm) collections benefit from percutaneous drainage. In cases of giant abscesses, percutaneous drainage achieved similar cure rates to surgical incision but with lower morbidity and shorter hospital stay, supporting a minimally invasive preference when feasible.

Management of Pyogenic Liver Abscesses publication trend

The graph below shows the total number of articles in management of pyogenic liver abscesses across all publications each year (not limited to Nature Index journals).

Technical terms

Percutaneous drainage: Minimally invasive evacuation of an abscess via catheter insertion under imaging guidance.

Glycaemic control: Regulation of blood glucose levels within a target range to reduce complication risk.

16S rRNA sequencing: Molecular technique targeting the ribosomal RNA gene to identify bacterial species in clinical specimens.

References

1. Comprehensive analysis of the microbiome and metabolome in pus from pyogenic liver abscess patients with and without diabetes mellitus. Frontiers in Microbiology (2023).
2. Massive Sequencing of V3-V4 Hypervariable Region in Pyogenic Liver Abscesses Reveals the Presence of Unusual Bacteria Not Detected by Classical Culture Methods. Microorganisms (2025).
3. Diabetes and obesity and risk of pyogenic liver abscess. Scientific Reports (2023).
4. Modern management of pyogenic hepatic abscess: a case series and review of the literature. BMC Research Notes (2011).
5. Clinical Charateristics and Outcome of Pyogenic Liver Abscess with Different Size: 15-Year Experience from a Single Center. Scientific Reports (2016).